The CD19 Lentivirus is a valuable tool for efficient gene delivery, designed for the consistent expression of human CD19 in various mammalian cells. This replication-incompetent, HIV-based lentiviral particle is pseudotyped with VSV-G, making it suitable for both primary and non-dividing cells. The EF1A promoter drives the expression of CD19, which is crucial in research related to B-lymphocyte biology and immunotherapy for lymphomas and leukemias.
- Replication-incompetent virus ensures safety for BSL-2 facilities.
- Pseudotyped with VSV-G for broad cell tropism.
- Suitable for transient expression and stable cell line generation.
- Produced in HEK293T cells.
- Available in two 500 μl vials.
- Titer of ≥10^7 TU/ml, lot-dependent.
- Stores at -80°C for up to 12 months.
- Shipped on dry ice.
- Supplied in culture medium containing 90% DMEM and 10% FBS.